Yankaskas, Christopher L.
Thompson, Keyata N.
Paul, Colin D.
Vitolo, Michele I.
Mistriotis, Panagiotis http://orcid.org/0000-0002-8069-3278
Mahendra, Ankit http://orcid.org/0000-0002-6664-5974
Bajpai, Vivek K.
Shea, Daniel J.
Manto, Kristen M.
Chai, Andreas C. http://orcid.org/0000-0001-8651-0164
Varadarajan, Navin
Kontrogianni-Konstantopoulos, Aikaterini
Martin, Stuart S.
Konstantopoulos, Konstantinos http://orcid.org/0000-0003-2623-1459
Article History
Received: 15 August 2018
Accepted: 5 April 2019
First Online: 6 May 2019
Competing interests
: The PTEN<sup>−/−</sup> cells are licensed to Horizon Discovery Ltd (Cambridge, UK). M.I.V receives compensation for the sale of these cells. MAqCI is the subject of US Utility Patent applications 15/780,768 and 14/906,055.